Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Large-Volume Hyperthermia for Safe and Cost-Effective Targeted Drug Delivery Using a Clinical Ultrasound-Guided Focused Ultrasound Device.

Lyon PC. et al, (2021), Ultrasound Med Biol, 47, 982 - 997

Quantifying cell death induced by doxorubicin, hyperthermia or HIFU ablation with flow cytometry.

Lyon PC. et al, (2021), Sci Rep, 11

Role of diffusion-weighted imaging in monitoring treatment response following high-intensity focused ultrasound ablation of recurrent sacral chordoma.

Chetan MR. et al, (2019), Radiol Case Rep, 14, 1197 - 1201

Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.

Lyon PC. et al, (2019), Ultraschall Med

Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.

Gray MD. et al, (2019), Radiology

Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer.

Lyon PC. et al, (2018), Radiol Case Rep, 13, 1259 - 1266

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.

Lyon PC. et al, (2018), Lancet Oncol, 19, 1027 - 1039

High-intensity focused ultrasonic ablation of sacral chordoma is feasible: a series of four cases and details of a national clinical trial.

Gillies MJ. et al, (2017), Br J Neurosurg, 31, 446 - 451

Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.

Lyon PC. et al, (2017), J Ther Ultrasound, 5

TARDOX: Safety and Feasibility of Targeted Delivery of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) By Focused-Ultrasound Hyperthermia for Liver Tumours

Odondi LET. et al, (2016)

Esophageal Atresia: Improved Outcome in High-Risk Groups Revisited

Malakounides G. et al, (2016), European Journal of Pediatric Surgery, 26, 227 - 231

Native nephrectomy in pediatric transplantation-Less is more!

Fraser N. et al, (2013), Journal of Pediatric Urology, 9, 84 - 89

Re: Native nephrectomy in pediatric transplantation - Less is more!

Fraser N. et al, (2013), Journal of Urology, 190

Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.

Miller S. et al, (2011), Neuro Oncol, 13, 866 - 879

Atypical presentation of purpura fulminans following sepsis in an adult

Lyon P. et al, (2011), BMJ Case Reports

Multimodal microglia imaging of fiber tracts in acute subcortical stroke

Radlinska BA. et al, (2009), Annals of Neurology, 66, 825 - 832

Planning and Delivery of Ultrasound- Mediated Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial

MIDDLETON MR. et al, Radiology

Include forthcoming?